Top Markets
Coin of the day
Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd.

TARO
Rank in Stocks #7354
Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven... Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven pharmaceutical enterprise, specializing in the development, manufacturing, and commercialization of both prescription and over-the-counter medications. Its market reach spans the United States, Canada, Israel, and various other international territories. The company also produces active pharmaceutical ingredients (APIs), primarily for integration into its own finished dosage form products. Its extensive product catalog addresses a broad spectrum of medical conditions and therapeutic areas, encompassing treatments for allergies, pain (analgesic), bacterial and fungal infections (antibacterial, antibiotic, antifungal), seizures (anticonvulsant), nausea (antiemetic), inflammation (anti-inflammatory), cancer (anti-cancer, topical anti-neoplastic), blood clot prevention (antiplatelet agent), fever reduction (antipyretic), cardiovascular issues, central nervous system disorders, hormonal regulation (corticosteroid, endocrine), cosmetic applications, coughs and colds, dermatological complaints, fluid management (diuretic), gastrointestinal problems, constipation (laxative), severe pain (narcotics), neuropathic pain, neuropsychiatric conditions, and sleep/anxiety management (sedative/hypnotic). These pharmaceutical goods are available in numerous formats, including capsules, creams, drops, emulsions, gels (and gel kits), granules, injectables, lotions, oils, ointments, pastes, powders (and powders for solution), rectal suppositories, shampoos, solutions (and solutions for infusion), sprays, suspensions, syrups, tablets, toothpastes and mouthwashes, topical foams, and topical solutions. Taro distributes and sells its products directly to a wide array of clients, such as pharmaceutical wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, other direct purchasers, and various healthcare institutions and private pharmacies. The company was established in 1950, with its main offices situated in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a wholly-owned subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.
Share Price
$42.98
Last synced: 2024-06-21
Market Cap
$1.62B
Change (1 day)
0.01%
Change (1 year)
0.00%
Country
IL
Trade Taro Pharmaceutical Industries Ltd. (TARO)

Category

P/E ratio for Taro Pharmaceutical Industries Ltd. (TARO)
P/E ratio as of August 2026 TTM: 30.05
According to Taro Pharmaceutical Industries Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 30.05. At the end of 2023 the company had a P/E ratio of 35.92.
P/E ratio history for Taro Pharmaceutical Industries Ltd. from 1999 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
2026 (TTM) 30.05 1.98%
2024 29.47 -17.98%
2023 35.92 28.54%
2022 27.95 -497.43%
2021 -7.03 -172.97%
2020 9.64 -36.03%
2019 15.07 -19.08%
2018 18.62 76.40%
2017 10.55 -6.95%
2016 11.34 -9.07%
2015 12.47 -8.53%
2014 13.64 38.57%
2013 9.84 52.53%
2011 6.45 -29.15%
2010 9.11 198.06%
2009 3.06 -69.11%
2008 9.89 27.00%
2007 7.79 -319.39%
2006 -3.55 -104.93%
2005 71.98 -19.62%
2004 89.55 194.34%
2003 30.42 25.42%
2002 24.26 -32.60%
2001 35.99 8.92%
2000 33.04 25.29%
1999 26.38 0.00%
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.